Xiaolin Zhu

751 citations
30 papers · 588 indexed · h-index 14
Topics
Nuclear Receptors and Signaling (4 papers)Cancer Mechanisms and Therapy (3 papers)Hepatocellular Carcinoma Treatment and Prognosis (3 papers)

In The Last Decade

Xiaolin Zhu

28 papers receiving 578 citations

Peers

Xiaolin Zhu
Comparison fields: 5 of 84
  • Molecular Biology 177
  • Cellular and Molecular Neuroscience 134
  • Immunology 134
  • Epidemiology 96
  • Hepatology 86
Replace Karlheinz Kiehne with:
Karlheinz Kiehne Germany
Armelle Le Campion France
Michael D. Josephs United States
Francesca Masciopinto Italy
Roberta Paolinelli Italy
Werner Dammermann Germany
Wim Van Molle Belgium
Xiaolei Sun China
Shogo Kawaguchi Japan
Kosuke Kozaiwa Japan
Xiaolin Zhu relative to Karlheinz Kiehne Germany Karlheinz Kiehne's profile →
Citations per field
00.5×6.9×
Karlheinz Kiehne · 1×
Citations per year

Countries citing papers authored by Xiaolin Zhu

Since Specialization
Citations

This map shows the geographic impact of Xiaolin Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolin Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolin Zhu more than expected).

Fields of papers citing papers by Xiaolin Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolin Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolin Zhu. The network helps show where Xiaolin Zhu may publish in the future.

Co-authorship network of co-authors of Xiaolin Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolin Zhu. A scholar is included among the top collaborators of Xiaolin Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolin Zhu. Xiaolin Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 4
4 10
5 0
6 7
7 2
8 17
9 9
10 26
11 17
12 13
13 10
14 16
15 41
16 16
17 43
18 6
19 48
20 107

About Xiaolin Zhu

Xiaolin Zhu is a scholar working on Hepatology, Cellular and Molecular Neuroscience and Internal Medicine, having authored 30 papers that have together received 588 indexed citations. Recurring topics across this work include Nuclear Receptors and Signaling (4 papers), Cancer Mechanisms and Therapy (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). The work is most often cited by research in Hepatology (86 citations), Cellular and Molecular Neuroscience (134 citations) and Immunology (134 citations). Xiaolin Zhu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include W. Timothy Garvey, Yuchang Fu, Nanlan Luo, Genmao Cao, Ti Zhang, Huikai Li, Kai Wei, Yunlong Cui, Zhengui Yan and Rui‐Liang Zhu. Their work appears in journals such as Journal of Biological Chemistry, Carbohydrate Polymers and Journal of Lipid Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026